Novel Neurotherapeutics

The remarkable advances in animal models, genetics, biomarker development, and drug discovery have led to the development of novel neurotherapeutics. Innovative treatments include neurochemical and molecular targets, genes and epigenetic therapies, cognitive construct-based behavioral interventions, as well as neural circuitry-based therapies such as deep brain stimulation and magnetic stimulation.

  • Neurotransmitters, neuromodulators, and neuroreceptors
  • Centrally acting analgesics
  • Blood brain barrier (BBB)
  • Metabolism mediated drug-drug interactions
  • Enzyme kinetics
  • Role of drug metabolism in drug development
  • Neurological Drug Targets

Related Conference of Novel Neurotherapeutics

April 23-24, 2026

8th World Depression Congress

Paris, France
May 14-15, 2026

9th World Conference on Neuroscience

Rome, Italy
June 22-23, 2026

7th World Congress on Sleep Disorders and Therapeutics

Amsterdam, Netherlands
June 22-23, 2026

18th Global Neurologists Meeting on Neurology and Neurosurgery

Amsterdam, Netherlands
June 22-23, 2026

38th World Conference on Neurology

Barcelona, Spain
June 29-30, 2026

37th Conference on Clinical Neuroscience and Neurogenetics

Aix-en-Provence, France
June 29-30, 2026

39th European Neurology Congress

London, UK
July 20-21, 2026

37th World Congress on Neurology and Neuroscience

Amsterdam, Netherlands
July 23-24, 2026

14th International Conference on Cannabis & Medicinal Research

Amsterdam, Netherlands
July 23-24, 2026

16th Global Alzheimers Summit

Paris, France
September 18-19, 2026

21st Annual Congress on Neuroscience

Dubai, UAE
November 16-17, 2026

8th World Brain Congress

Tokyo, Japan

Novel Neurotherapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in